3-50269265-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001290060.2(SEMA3B):c.25G>A(p.Val9Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000702 in 1,537,514 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001290060.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3B | NM_001290060.2 | c.25G>A | p.Val9Met | missense_variant | 1/17 | ENST00000616701.5 | NP_001276989.1 | |
SEMA3B | NM_001290061.1 | c.25G>A | p.Val9Met | missense_variant | 1/17 | NP_001276990.1 | ||
SEMA3B | NM_004636.4 | c.25G>A | p.Val9Met | missense_variant | 2/18 | NP_004627.1 | ||
SEMA3B | NM_001005914.3 | c.25G>A | p.Val9Met | missense_variant | 2/18 | NP_001005914.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000201 AC: 27AN: 134482Hom.: 1 AF XY: 0.000178 AC XY: 13AN XY: 72960
GnomAD4 exome AF: 0.0000643 AC: 89AN: 1385210Hom.: 1 Cov.: 31 AF XY: 0.0000600 AC XY: 41AN XY: 683652
GnomAD4 genome AF: 0.000125 AC: 19AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74462
ClinVar
Submissions by phenotype
SEMA3B-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The SEMA3B c.25G>A variant is predicted to result in the amino acid substitution p.Val9Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.049% of alleles in individuals of East Asian descent in gnomAD, including one homozygous individual. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at